Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials

Mol Cancer. 2023 Jun 27;22(1):101. doi: 10.1186/s12943-023-01812-z.

Xianjing Chu^#¹, Wentao Tian^#¹, Ziqi Wang¹, Jing Zhang², Rongrong Zhou^{3

4

5}

¹ Department of Oncology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha, 410008, China.
² Department of Oncology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha, 410008, China. zj782@csu.edu.cn.
³ Department of Oncology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha, 410008, China. zhourr@csu.edu.cn.
⁴ Present Address: Xiangya Lung Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. zhourr@csu.edu.cn.
⁵ National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, Changsha, 410008, People's Republic of China. zhourr@csu.edu.cn.

^# Contributed equally.

No abstract available

Publication types